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Abstract
Background: We have used a linear mixed model (LMM) approach to examine the joint contribution of genetic
markers associated with a biological pathway. However, with these markers being scattered throughout the genome,
we are faced with the challenge of modelling the contribution from several, sometimes even all, chromosomes at
once. Due to linkage disequilibrium (LD), all markers may be assumed to account for some genomic variance; but the
question is whether random sets of markers account for the same genomic variance as markers associated with a
biological pathway?
Results: We applied the LMM approach to identify biological pathways associated with udder health and milk
production traits in dairy cattle. A random gene sampling procedure was applied to assess the biological pathways in
a dataset that has an inherently complex genetic correlation pattern due to the population structure of dairy cattle,
and to linkage disequilibrium within the bovine genome and within the genes associated to the biological pathway.
Conclusions: Several biological pathways that were significantly associated with health and production traits were
identified in dairy cattle; i.e. the markers linked to these pathways explained more of the genomic variance and
provided a better model fit than 95% of the randomly sampled gene groups. Our results show that immune related
pathways are associated with production traits, and that pathways that include a causal marker for production traits
are identified with our procedure.
We are confident that the LMM approach provides a general framework to exploit and integrate prior biological
information and could potentially lead to improved understanding of the genetic architecture of complex traits and
diseases.
Background
Genome-wide association studies (GWAS) focus on
determining which genes or mutations contribute to a
given trait or disease phenotype by looking at each
genetic variant one at a time [1]. In this approach, it is
assumed that the trait or disease phenotype is inherited
in a Mendelian fashion. However, in animal breeding the
objective is to use all available genetic variants simultane-
ously to predict breeding values, since the traits of interest
are complex traits such as body weight, disease suscepti-
bility, or production of milk. The current understanding
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of complex traits is that the phenotype is expressed as
a result of the interplay between molecular and cellu-
lar components, each component interacting at various
levels (e.g. cell, molecule, RNA, DNA) that are entan-
gled in various biological pathways. This fits well with an
infinitesimal model, for which it is assumed that a large
number of genetic variants contribute to the trait, each
with a small effect.
Issues on how complex traits are regulated give rise
to the problem of ‘missing heritability’ [2]. This problem
occurs when the objective is to estimate how much of the
genomic variance can be explained by the genetic vari-
ants identified in a traditional GWAS, e.g. in which the
genetic variants are tested individually. After accounting
for non-genetic effects (e.g. sex and environmental effects)
for an observed phenotype, and adjusting for multiple
© 2015 Edwards et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
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testing, the genetic variants that are determined to be
significantly associated cannot explain all the observed
genomic variance. Makowsky et al. [3] lists some expla-
nations such as poor genetic models (e.g. unaccounted
epistatic effects), insufficient sample sizes or rare genetic
variants, but highlights the work of Yang et al. [4], who
suggest that the statistical modelling framework does not
match the genetic architecture.
Evidence collected across numerous GWAS reveals pat-
terns that provide insight into the genetic architecture of
complex traits [5, 6]. Although many genetic variants with
small or moderate effects contribute to the overall genetic
variation, it appears that the genetic variants associated
with trait variation are preferentially located in genes that
are connected within biological pathways [5].
These biological findings are useful to improve sta-
tistical models that aim at associating genetic variation
with the phenotypes of interest. There are several statis-
tical modelling approaches that can be used to evaluate
the collective action of multiple genetic variants within
biological pathways or other genomic features (e.g. reg-
ulatory elements or genes) [7–10]. A commonly used
two-step approach is the SNP (single nucleotide poly-
morphism) set enrichment analysis [7]. In this approach,
the first step consists in using SNPs as proxies for causal
genetic variants to obtain test statistics (e.g. t-statistics
or p-values) from traditional single-marker or all-marker
statistical models for the association between a pheno-
type and individual markers. In the second step, for each
genomic feature being tested, an enrichment score is cal-
culated (e.g. an overrepresentation of associated markers
in the genomic feature). SNP set enrichment analysis is
commonly used because it is computationally fast and
is easily combined with association data from previous
GWAS. The downside of these approaches is that they
typically only use the highest scoring SNPs, thus neglect-
ing markers that potentially each contribute very small
effects [10].
The linear mixed model approach proposed by Yang
et al. [4] and Jensen et al. [11] circumvents this issue by
partitioning the genome according to chromosomes and
then modelling the markers in each chromosome concur-
rently. Using this approach, they were able to determine
the proportion of genomic variance that is explained by
markers on each chromosome. One major advantage of
thismodelling approach is that it does not require a cut-off
of p-values, but instead it considers all markers, whether
they have a large or small effect. This is consistent with
the idea that a complex trait is caused by multiple markers
with small to moderate effects.
To enhance the analysis and biological interpreta-
tion, instead of partitioning according to the physical
structuring of genes (i.e. chromosomes), we applied exter-
nal information, evidence that was obtained from other
experiments or from other organisms through homol-
ogy, to the partitioning concept; here we used the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [12, 13].
Thus, we were able to answer questions such as ‘How
much of the observed phenotypic variance is accounted
for by markers linked to a specific biological pathway?’
Although it is straightforward to determine a variance
component for a group of markers or a pathway of inter-
est, it is not so easy to determine whether it represents a
significant amount of genomic variance. The linear mixed
model approach allows us to use a likelihood ratio test
(LRT) to compare different pathway-based partitionings
of the genomic variance. However, genes and markers
that can be associated to biological pathways are scattered
throughout the genome (Fig. 1) and this may influence the
distribution of the likelihood ratios. Furthermore, under
the infinitesimal model, we expect that an infinite number
of markers contribute to the observed genomic variance,
and therefore we must also determine whether the vari-
ance contributed by the markers of interest is larger than
that of the same number of randomly sampled markers.
The aims of this study were to: (1) implement a linear
mixed model approach to quantify the collective action of
multiple markers within biological pathways on a complex
trait, (2) to evaluate testing strategies to assess whether the
proportion of explained genomic variance by a set of ‘scat-
tered’ markers is statistically significant and larger than
the proportion explained by a randomly sampled set of
markers, and (3) to apply this modelling approach to iden-
tify biological pathways associated with udder health and
milk production traits in dairy cattle.
Methods
Genotype data
Genotype data for 4497 Danish Holstein bulls was
obtained using Illumina BovineHD (777k) and Bovi-
neSNP50 (50k) SNP arrays. The 50 k genotype data was
imputed to the HD level using BEAGLE [14]. For more
details see [15]. After filtering for markers with a min-
imum allele frequency greater than 0.01, 637951 SNPs
were available for analysis.
Trait data
Records for udder health and production traits were avail-
able for 4497 bulls and are summarised in Table 1. Health
traits were estimated breeding values (EBV) for clinical
mastitis from 15 days before to 50 days after first calving
(‘Mastitis 1.1’), clinical mastitis from 51 to 305 days after
first calving (‘Mastitis 1.2’), average somatic cell score dur-
ing the period between 5 amd 305 days after first calving
(‘Somatic Cell Score 1’), and a composite index ‘Udder-
health’ [16]. Production traits were ‘Fat yield’, ‘Milk yield’,
and ‘Protein yield’, expressed as deregressed proofs (DRP)
of trait indices during lactation periods after first, second,
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Fig. 1 Chromosomal location of genes associated with the KEGG pathway Immune System. The pathway consists of several sub-pathways and
genes that can be associated to none, one or several pathways. Since the chromosomal location of the genes is known, it is possible to link a
pathway to a set of markers
and third calving. See [16] for further description of the
traits. DRP were based on EBV and associated reliabili-
ties from routine genetic evaluations conducted by Nordic
Cattle Genetic Evaluation [16]. Deregression was per-
formed by the iterative procedure of [17] implemented in
MiX99 [18, 19].
Mapping pathways to genes to markers
The SNPs on the HD array are mapped to the UMD3.1
Bovine Genome assembly [20]; gene maps for this assem-
bly were downloaded September 1st 2011 from the
website ftp://ftp.cbcb.umd.edu/pub/data/assembly/Bos_
taurus/Bos_taurus_UMD_3.1/annotation/UMD3.1.gff.gz,
containing 26352 genes with an Entrez Gene ID. Amarker
was associated with a gene if the chromosomal position
of the marker was between the start and stop chromoso-
mal position of the gene. We attempted to determine the
maximum possible distance between marker and gene for
a marker to be associated with a gene for distances rang-
ing from 0 to 50 kbp (both upstream and downstream)
by calculating variance components as described in the
section ‘Linear mixed models’. Comparison between the
proportion of explained genomic variance and distance
gave no definitive conclusion, so we arbitrarily chose not
to include markers located outside a gene. This resulted
in 39% (251436/637951) of the SNPs being mapped to
17664 genes. Although on average there were 14 SNPs
per gene, 3676 of the genes had only a single mapped SNP.
At the other extreme, 369 genes had more than 100 SNPs
mapped to them, with one gene having 645 SNPs mapped
to it.
KEGG pathways were obtained from the KEGG’s
website http://www.genome.jp/kegg-bin/get_htext?org_
name=br08901&htext=br08901.keg&hier=2 and manu-
ally curated into a map-file that describes the pathways in
the sectionsMetabolism, Genetic Information Processing,
Table 1 Summary of the traits analysed
Trait Number of observations Average (Std.dev) Record type Random gene groups Pathways
Health traits
Mastitis 1.1 4491 95.8 (9.7) EBV 5553 150
Mastitis 1.2 4394 96.3 (9.7) EBV 5557 150
Somatic Cell Score 4492 96.8 (10) EBV 5550 150
Udder-health 4497 96.1 (9.6) EBV 5551 150
Production traits
Fat yield 4398 97.0 (12) DRP 5591 149
Milk yield 4398 97.4 (13) DRP 5592 150
Protein yield 4398 95.4 (15) DRP 5596 148
EBV: Estimated Breeding Values; DRP: Deregressed Proof; Std.dev: Standard deviation
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Enviromental Information Processing, Cellular Processes,
and Organismal Systems. Associations between KEGG
pathways and genes were extracted from the database
file of the BioConductor package ‘org.Bt.eg.db’ v. 2.6.4
[21, 22]. This resulted in 4490 genes associated to KEGG
pathways. A SNP was associated with a pathway if it
resided within a gene linked to the pathway, and was only
associated once per pathway.
SNPs located in genes that were associated with KEGG
pathways are present throughout the entire genome, as
shown in Fig. 1 for the pathways in the ‘Immune System’
group. This figure is typical for all the pathways that we
could map genes to, and shows that the clustering of genes
is different for each chromosome and pathway, with some
pathways occupying long stretches of chromosomes. It
should be noted that for a given pathway, SNPs associated
with the pathway can be both in close proximity, at a great
distance, or even on different chromosomes. This implies
that selecting SNPs based on a single pathway will include
information on SNPs from across the entire genome, some
of which might be in high correlation with a causative
locus.
For milk production, it has been shown that the gene
DGAT1 (diacylglycerol O-acyltransferase 1) contains a
causative nucleotide [23], which violates our null hypoth-
esis that all SNPs contribute equally to genetic variance,
and thus, we expect that this will affect the outcome of the
analyses. Due to linkage disequilibrium (LD), we expect
that genes that are localized nearby to DGAT1 will also
have an effect. Thus, we arbitrarily defined that the genes
located within 500 kbp of DGAT1 constitute a group of
genes, which we named ‘DGAT1 genes’ (see Additional file
1: Table S1).
Linear mixedmodel approach
By partitioning the markers into two groups, S and ¬S ,
based on e.g. biological pathways or random gene groups,
we used the following two-component linearmixedmodel
tomodel the joint contribution of each set of markers. The
model consists of two genetic effects, each modelled by
a genomic relationship matrix, where each matrix is con-
structed from a set of markers. It can be written in linear
form as:
y = 1μ + gS + g¬S + e, (1)
where y is a 1 × n vector of phenotypic observations,
n the number of animals, μ the mean, gS is the n
length vector of genetic effects for the markers in set
S , and similarly for ¬S , and e the vector of residu-
als. The assumptions for the random effects are given
by:
⎛
⎝ gSg¬S
e
⎞
⎠ ∼ N
⎡
⎣
⎛
⎝ 00
0
⎞
⎠ ,
⎛
⎝GSσ
2
S 0 0
0 G¬Sσ 2¬S 0
0 0 Dσ 2e
⎞
⎠
⎤
⎦ ,
(2)
GS is the genomic relationship matrix, an n × n matrix,
calculated as WW′mS , with W as the centered and scaledmarker incidence matrix for themS markers in S [24].
G¬S is similar, except for markers in¬S .D is the matrix
of weights for the residuals, here a n × n diagonal matrix.
For the health traits, this was equal to the identity matrix,
and for the production traits, the diagonal was equal to
the weights calculated as r21−r2 , where r is the reliability
of the DRP. σ 2S , σ 2¬S , and σ 2e are the variance compo-
nents to be estimated for the genetic values and residuals,
respectively.
A genomic relationship matrix constructed from a set
of markers can describe pedigree-based relationships, i.e.
the family structure [24]. In our case, G¬S is always con-
structed based on at least 90% of the markers, thus we
expect that the population structure is always described
[25, 26].
Under the infinitesimal model, it is assumed that all
markers are equal when modelling their contribution to
the genetic variance. The above model can therefore be
reduced to a ‘simple model’ which serves as the competi-
tive null hypothesis that variance is spread equally across
all markers. Using the same notation as above, the simple
model can be written as:
y = 1μ + g + e, (3)
with assumptions as:
( g
e
)
∼ N
[( 0
0
)
,
(Gσ 2g 0
0 Dσ 2e
)]
, (4)
which is identical to (1) when σ 2g /m = σ 2S/mS =
σ 2¬S/m¬S ,
(where m is the total number of markers). Thus the two
models are nested. A proof of this follows by rewrit-
ing G = WW′m , and likewise for GS and G¬S on their
respective subset of markers.
Gσ 2g = GSσ 2g
mS
m + G¬Sσ
2
g
m¬S
m
WW′
m σ
2
g =
WSW′S
mS
σ 2g
mS
m +
W¬SW′¬S
m¬S
σ 2g
m¬S
m (5)
WW′
m σ
2
g =
WSW′S + W¬SW′¬S
m σ
2
g .
This notation makes it clear that the null-hypothesis
does not assume that σ 2S = 0, but rather that the variance
components are equal when weighted by the respective
proportions of SNPs that they represent.
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We can relate the model in (1) to the model often used
in GWAS, where the set S contains only a single marker:
y = 1μ + gS + g + e,
where gS ∼ N
(
0, WSW
′
S
mS σ
2
S
)
and g ∼ N
(
0, WW′m σ 2g
)
,
i.e. the latter contains all markers. The corresponding null
model for this model is the same as our null model in (3)
and a standard LRT will test whether σ 2S > 0. The GWAS
model is similar to our model since it also attempts to
capture the effect of a part of the genome, but differs in
that the marker examined is included twice: i.e. both in gS,
and in g via the construction of G. In our approach, the
marker is only included once, and according to (5), LRT
results should be easily interpreted. Recently, Yang et al.
[27] showed that partitioning markers increased power
to detect single marker associations and Speed and Bald-
ing [28] applied partitioning inMultiBLUP, which includes
multiple random effects, each modelled by a subset of
markers.
Estimation of parameters
The variance components were estimated using an aver-
aged information restricted maximum likelihood (AI-
REML) [29, 30] in the software DMU [31]. Special care is
necessary to interpret the results of the AI-REML algo-
rithm since it sometimes converges on a meaningless
result; this happens when a variance component is close
to zero, the likelihood ratio is negative, or as we found, the
algorithm estimated 4 times more variance than present
in the data. Our results were visually inspected for these
shortcomings; less than 10 of more than 5500 random
gene groups in each trait displayed this type of behaviour
and were subsequently removed from the results, as well
as one or two pathways for each of the production traits.
The proportion of explained genomic variance by a gene
group S , was calculated as:
H2set =
σ 2S
σ 2S + σ 2¬S
. (6)
A priori, all markers are expected to explain an equal
amount of observed variance. Therefore, the ratio of
expected variance for any marker group S withmS mark-
ers from a total of m markers is expected to account for a
proportionmS/m of the observed genomic variance.
Likelihood ratio tests
The linear mixed model approach allows us to use a LRT
to compare different pathway-based partitionings of the
genomic variance. Likelihood ratios (LR) were calculated
as twice the difference between the log-transformed like-
lihood of the simple model (3) and the full model (1).
Standard theory describes that the LRT statistic used for
this is distributed as χ2κ , where κ is the number of degrees
of freedom and is equal to the difference in number
of parameters between models [32]. When partitioning
markers into two groups, given the chromosomal position
of the markers, we expect the two groups to be correlated,
although the model in (2) states that they are not. To what
extent this partitioning influences the distribution of the
LR is unclear. Thus, we determined the properties of LRT
under these non-standard conditions using the random
gene sampling procedure described below. This procedure
will also take variation in the properties of groups into
account, such as differences in allele frequencies, number
of markers, and extent of LD, without attempting tomodel
these properties explicitly.
Random gene groups for empirical distributions
We applied a random sampling procedure to generate data
under the competitive null hypothesis [33] that all markers
are expected to account for the same amount of variance.
This procedure differs greatly from a permutation test,
which is typically used for a self-contained null hypothe-
sis, in which a marker is expected to not account for any
variance.
For each random gene group, a target number of
markers was drawn uniformly within the range from 1
to 50 000. Genes were then sampled uniformly without
replacement, until the total number of unique markers
associated with these genes exceeded the target number.
Variance components were estimated for each random
gene group for each trait, resulting in more than 5500
data-points for each trait (see Table 1), each data-point
consisting of the number of markers in the group (‘group
size’), the ratio of variance explained by that group (H2set –
see eq. 6), and the LR statistic.
An empirical threshold for H2set and LR was then calcu-
lated for each trait as a function of the number of markers
by applying a smooth quantile regression from the R-
package ‘quantreg’ [34–36] on the random gene groups
at the 50th and 95th percentile, setting λ = 500 and
the constraint as ‘increasing’. The empirical thresholds are
referred to as H295 and LR95.
Correcting formultiple testing and false discovery rate
Based on empirical distributions of LR statistics, we
applied a classical χ2 test of the LR statistics on each
KEGG pathway with either 1 or 2 degrees of freedom
(cf. results fromKolmogorov-Smirnov test).With p-values
obtained from the χ2 distribution, the false discovery rate
(FDR) was adjusted using the Benjamini and Hochberg
method [37] using the ’p.adjust’-function in R v. 3.0.2 [38].
Results
Likelihood ratios
Distributions of LR statistics are compared in Fig. 2 where
the random gene groups are presented according to group
size in intervals of 10000 markers. This revealed that the
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Fig. 2 QQ-plot of the observed likelihood ratios (LR) of random gene groups vs. theoretical χ21 -distribution showing that they are skewed towards
higher values than χ21 . LR displayed for the traits Mastitis 1.1 (top) and Fat yield (bottom), conditional on whether the gene groups contain one of
the DGAT1 genes (left/right) and group size (colour). Please note that the range of the y-axes differs between the top and bottom
distributions for group sizes smaller than 10000 mark-
ers differed in a trait-dependent way. For fat yield, the LR
distribution was skewed towards larger values, whereas
the LR distribution for health traits was slightly skewed
towards smaller values, when the gene group included one
of the DGAT1 genes. We also found a weak, but signifi-
cant increase in the 95th percentile of the LR statistics for
different group sizes. Therefore, to better account for the
influence of group size in the LRT, we used the quantile
regression approach [34–36] to determine a 95% cut-off
adjusted for group size and the DGAT1 genes in the gene
groups.
We used the Kolmogorov-Smirnov test statistic to com-
pare the empirical LR distributions to a χ2 distribution
(see Additional file 2: Figure S1) and found that all traits,
except two, had a smaller Kolmogorov-Smirnov test statis-
tic for a χ2 distribution with one degree of freedom, than
two degrees of freedom or a mixture of one and two
degrees of freedom. I.e. the empirical LR distributions
were more similar to a χ2 distribution with one degree of
freedom. The two exceptions were ‘Fat yield’, which had a
smaller test statistic for a χ2 distribution with two degrees
of freedom, and ‘Milk yield’, which had the smallest test
statistic for a mixture of the two χ2 distributions.
Proportion of genomic variance explained
To illustrate how much of the genomic variance was
explained by a randomly sampled group of genes, results
for two trait are presented: a health trait (Mastitis 1.2 in
Fig. 3) and amilk production trait (Fat yield in Fig. 4). Sim-
ilar plots for all traits are in Additional file 2: Figures S2,
S3, S4, S5, S6, S7, and S8.
In Figs. 3 and 4, the 50th and 95th percentiles for the
proportion of genomic variance explained by groups of
random genes clearly show an increase with increasing
group size. The maximum amount of genomic variance
explained by any gene group amounted to about 25% and
50% for milk yield and fat yield, respectively, whereas
for protein yield and health traits, the maximum was
22%. For the production traits, fat and milk yield, the
influence of DGAT1 on the amount of genomic variance
explained was clear, since there were large differences
in the H2set-percentiles. For protein yield and the health
traits, there was no difference between the regression lines
for gene groups withDGAT1 genes and gene groups with-
outDGAT1 genes, since this gene is not causative for these
traits.
In Figs. 3 and 4, samples with LR statistics greater than
the 95% percentile (i.e. LR ≥ LR95) are highlighted, and in
general, we found that gene groups that explained a large
proportion of genomic variance also provided a better
model fit. There was however a number of gene groups,
that did not explain any of the variance, but still provided
a good model fit.
Criteria to determine the significance of a given gene group
Based on the empirical distribution of the test statis-
tics from the random gene sampling procedure described
above, we used two criteria to determine if a given
pathway had a statistical significant better model fit or
explained more variance than expected:
LR95: Comparison of model fit. When LR ≥ LR95, group
S had a better fit than 95% of the random gene
groups.
H295: Estimated proportion of explained genomic
variance by markers in S exceeded that observed
for 95% of random gene groups of similar size. Our
interpretation is that when H2set ≥ H295, H2set is
larger than expected by chance for a group with the
same number of markers.
If both criteria were fulfilled, the partitioning of the sub-
set S provided both a better model fit and explained more
genomic variance than a random gene group, and thereby
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Fig. 3 Proportion of explained genomic variance by random gene groups for the trait Mastitis 1.2 as a function of number of markers in the gene
groups, showing that an increase in group size increases the expected amount of explained genomic variance. The dots corresponds to a random
gene group, and the lines are the 50th and 95th percentile of these. The random gene groups are colour coded according to whether the likelihood
ratio is larger than 95% of the likelihood ratios of the same trait. The regression lines are coloured according to whether they describe gene groups
containing DGAT1 genes; the grey, dashed line corresponds to the naïve expectation of the infinitesimal model, where all markers contribute with
the same effect
identified a gene group of particular biological interest.
Both criteria are based on a competitive test, as in ‘Could
we have found this result by randomly picking genes?’ and
is in principle different from testing whether a variance
component is different from zero (i.e. different from a
self-contained test).
Using these criteria, it is not possible to correct for mul-
tiple testing, since neither LR95 nor H295 provide p-values,
but are merely cut-off values. However, the similarity
between the theoretical χ2 and empirical distributions
allows for the use of a classical χ2 test with accompanying
adjustment of p-values, as demonstrated in the following.
Fig. 4 Proportion of explained genomic variance by random gene groups for the trait Fat yield as a function of number of markers in the gene
groups, showing that groups with DGAT1 genes consistently increase the expected amount of explained genomic variance. For groups that do not
contain one of the DGAT1 genes, the situation is the same as for Mastitis 1.2. The dots corresponds to a random gene group, and the lines are the
50th and 95th percentile of these. The random gene groups are colour coded according to whether the likelihood ratio is larger than 95% of the
likelihood ratios of the same trait. The regression lines are coloured according to whether they describe gene groups containing DGAT1 genes; the
grey, dashed line corresponds to the naïve expectation of the infinitesimal model, where all markers contribute with the same effect
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Table 2 Summary of significant KEGG pathways and combined pathways
Number of pathways to pass Combined pathways Number of pathways to pass
H295 LR95 Both Number of SNPs H
2
set χ
2 FDR
Health traits
Mastitis 1.1 20 20 18 8590 12.9 13 3
Mastitis 1.2 10 18 9 7959 11.1 12 0
Somatic Cell Score 11 8 8 2757 3.6 3 0
Udder-health 17 22 16 11514 13.7 14 1
Production traits
Fat yield 14 16 14 7639 19.7 11 8
Milk yield 15 19 14 10695 11.2 10 8
Protein yield 14 23 13 12076 9.8 19 5
The ‘Combined pathways’ combine all markers associated with pathways found significant for each trait into a single pathway. All seven ‘Combined pathways’ were found
significant by both LR95 and H295. H
2
set : Proportion of explained genomic variance. H
2
95 and LR95: Empirical cut-offs for H
2
set and LR. FDR: Benjamini and Hochberg p-value
adjustment
Biological pathways associated with health and
production traits in dairy cattle
Some KEGG pathways could not be mapped to the bovine
genome, or the AI-REML algorithm did not converge sat-
isfactory, which resulted in LR statistics and estimates
of genomic variance explained in between 148 and 150
gene groups, see rightmost column of Table 1. Table 2
summarizes how many of these KEGG pathways satisfied
the two criteria (LR95 and H295); generally, more path-
ways were found to pass LR95 than H295. For each trait,
5 % (for ‘Somatic Cell Score’) to 12% (for ‘Mastitis 1.1’)
of the KEGG pathways met both criteria. The health trait
‘Somatic Cell Score’ consistently had the smallest propor-
tion of explained genomic variance compared to the other
traits, which was also evident for the associated pathways.
Using the classical χ2 test, p-values could be calculated
using the closest χ2 distribution from the Kolmogorov-
Smirnov test, and adjusted for multiple testing. The num-
ber of pathways with a significant LR using a 10% FDR is
displayed in the rightmost column of Table 2. The number
of pathways that were significant with an unadjusted χ2
test is similar to that obtainedwhen using both empirically
derived criteria.
Figure 5 summarises the pathways that have a significant
LR after adjusting for multiple testing using FDR. The val-
ues for H2set, adjusted p-value, and LR statistics for these
pathways are in Table 3. After correcting for multiple test-
ing, there were no pathways associated with ‘Mastitis 1.2’
or ‘Somatic Cell Count’. A summary of all tested pathways
and traits is in Table S2 (see Additional file 3: Table S2).
Xenobiotics Biodegration and Metabolism
Metabolism of Other Amino Acids
Metabolism of Cofactors and Vitamins
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Fig. 5 Overview of all pathways significant for both empirical cut-offs of LR and H2set (LR95 and H
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Table 3 Values of significant KEGG pathways, after adjusting for multiple testing
Pathway Trait Number of SNPs H2set p-value LR
Amino Acid Metabolism
Arginine and proline metabolism Fat yield 390 13.8% 6 · 10−9 44.3
Carbohydrate Metabolism
Pentose phosphate pathway Mastitis 1.1 182 2.3% 4 · 10−2 11.6
Digestive System
Fat digestion and absorption Fat yield 436 43.4% 0 317
Fat digestion and absorption Milk yield 436 31.5% 0 184
Excretory System
Excretory System Mastitis 1.1 1639 3.6% 4 · 10−2 11.2
Proximal tubule bicarbonate reclamation Udder- health 187 1.2% 8 · 10−2 11.9
Proximal tubule bicarbonate reclamation Mastitis 1.1 187 2.2% 1 · 10−4 24.1
Proximal tubule bicarbonate reclamation Protein yield 187 1.5% 6 · 10−2 10.8
Glycan Biosynthesis andMetabolism
Glycosphingolipid biosynthesis - globo series Fat yield 91 1.4% 3 · 10−2 13.2
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis Fat yield 157 14.4% 0 91.6
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis Milk yield 157 10.3% 2 · 10−12 60.6
Immune System
Chemokine signaling pathway Milk yield 2809 5.3% 3 · 10−3 16.8
Leukocyte transendothelial migration Milk yield 2001 4.6% 5 · 10−3 15.6
Leukocyte transendothelial migration Fat yield 2001 4.5% 6 · 10−3 16.4
Lipid Metabolism
Glycerolipid metabolism Milk yield 969 27.9% 7 · 10−12 57.4
Glycerolipid metabolism Fat yield 969 41.6% 0 157
Metabolism of Cofactors and Vitamins
Metabolism of Cofactors and Vitamins Milk yield 1796 21.9% 4 · 10−9 44.5
Metabolism of Cofactors and Vitamins Fat yield 1796 32.0% 3 · 10−12 59.7
Metabolism of Cofactors and Vitamins Protein yield 1796 3.4% 8 · 10−2 9.5
Porphyrin and chlorophyll metabolism Protein yield 194 3.0% 6 · 10−2 10.4
Retinol metabolism Fat yield 231 38.1% 0 382
Retinol metabolism Milk yield 231 28.9% 0 259
Retinol metabolism Protein yield 231 9.9% 2 · 10−9 45.5
Metabolism of Other Amino Acids
Glutathione metabolism Milk yield 231 2.9% 3 · 10−2 12
Xenobiotics Biodegration andMetabolism
Xenobiotics Biodegration and Metabolism Protein yield 860 1.9% 8 · 10−2 9.04
Displayed p-values are adjusted
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Two of the pathway groups were significant; ‘Excretory
System’ and ‘Metabolism of Cofactors and Vitamins’. The
pathway ‘Retinol metabolism’, which includes DGAT1, is
significant for all three production traits; it passes the two
criteria LR95 and H295 for all traits (except ‘Mastitis 1.1’,
which was only found significant by H295).
There is almost no overlap between pathways that were
significant for production traits and health traits. Only
the pathway ‘Proximal tubule bicarbonate reclamation’ is
significant for both ‘Udder-health’ and ‘Protein yield’, and
explains about the same amount of genomic variance in
the two traits.
Discussion
A LMM and a statistical testing strategy were presented to
examine the joint contribution of a marker set to a com-
plex trait, where the markers are located in gene groups
associated to a biological pathway.
Our LMM was based on partitioning the genomic vari-
ance into two components. One component due to the
markers in a gene group and another component due to
the remaining set of markers. The model was similar to
those proposed by Jensen et al. [11] and Listgarten et al.
[26] who also used multiple genomic variance compo-
nents. In their studies, they only investigated consecutive
regions of markers sets, i.e. individual genes or chromo-
somes, whereas we examined scattered sets ofmarkers; i.e.
the biological pathways.
We used two approaches to evaluate a gene group: LRT
and thresholds based on empirical distributions.
We used the LRT to evaluate the model fit of a gene
group. A high LR showed that the model with two
different genomic variance components performed better
to explain the observed genomic variance than a model
with only a single genomic variance component. It is
important to note that this LRT was different from a
standard LRT, which is used to test whether the vari-
ance component for a random effect is different from
zero. Our null hypothesis corresponds to the infinitesimal
model where all markers are - on average - contributing
with the same, albeit small effect. This corresponds to our
null model with a single genomic variance component.
Our alternative hypothesis is that the causal markers are
not randomly distributed over the genome, as in the null
hypothesis, but are clustered in gene groups that can be
associated to certain biological pathways. This is reflected
in our alternative model with two genomic variance com-
ponents. If the null hypothesis is true, we expect that the
null and alternative models lead to a similar fit. If the
alternative hypothesis is true, we expect that the alter-
native model to provide a better model fit. Furthermore,
under the null hypothesis, we expect that the proportion
of explained genomic variance by a gene group is propor-
tional to the number markers (or genome length covered)
by the gene group. Thus our LRT reflects the statistical
significance of the partitioning of the genomic variance.
However, a high LR alone does not indicate that a gene
group is biologically important since we observed several
gene groups with a high LR that explained close to none
of the genomic variance. Thus, it was necessary to use
both LR and proportions of explained genomic variance
to identify biological important gene groups.
To estimate the expected proportion of explained
genomic variance under the null hypothesis, we used a
resampling approach. Here, loci were used as sampling
units cf. the null hypothesis for which all markers were
expected to contribute. Thus our resampling approach
generated data under the null hypothesis. However, not
all loci were sampled, since we restricted the analysis to
sampling random gene groups to be able to compare with
gene groups associated to biological pathways. By using
the empirical distributions from the resampling approach,
we derived cut-off thresholds for both LR and explained
genomic variance. This was used to assess whether the
observed estimates of LR or explained genomic variance
for a biological pathway showed extreme values compared
to those for a random gene group with a similar number
of markers in this particular sample of Danish Holstein
animals. The p-values obtained by the LRT are concep-
tually different from the thresholds obtained from the
resampling described above. The p-values relate to true
biological replication of the experiment. A significant p-
value excludes random variation at the animal level as
an explanation for the associations found, and therefore
increases the confidence that the same associations will be
found for a new sample of animals from the same breed.
In spite of this different interpretation of the p-values, we
observed a large overlap between the biological pathways
that were determined to be ‘significant’ using either p-
values obtained from the LRT or the thresholds obtained
from the resampling procedure.
Empirical distribution of likelihood ratios
The empirical LR distribution for protein yield and the
health traits resembled a χ2 distribution with one degree
of freedom, whereas it was closer to a χ2 distribution with
two degrees of freedom for fat andmilk yield. A consistent
pattern across all traits was that the observed likelihood
ratios were skewed towards higher values at the right hand
tail of the empirical LR distribution, as compared to the
theoretical χ2 distribution with one degree of freedom.
This was not entirely unexpected since some of the ran-
dom gene groups were likely to harbour markers that are
linked to causal genetic variants. Examining the LR dis-
tributions, we could roughly divide the traits into two
groups: fat and milk yields, which are strongly affected by
DGAT1, and the health traits and protein yield, which are
less affected byDGAT1. However, for the health traits and
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protein yield, there was also a clear effect ofDGAT1, since
the 95th percentile of the LRwas significantly higher when
DGAT1 was included in the gene group. This could indi-
cate that the region that includes DGAT1 also harbours
genetic variants that are associated with the health traits.
Empirical distribution of proportion of explained genomic
variance
Based on the infinitesimal model, we would expect that
each marker contributes equally to the observed genomic
variance. A gene group with nmarkers would be expected
to account for n/ntotal of the genomic variance. The
median of explained genomic variance by the random
gene groups followed this expected proportion. This can
be considered as an argument in favour of the infinites-
imal model. There were, however, numerous samples for
which a small number of markers accounted for more of
the genomic variance than expected. Overall, these devia-
tions from the infinitesimal model are taken into account
in our testing procedure, by using random gene samples.
Biological pathways associated with udder health and
production traits
We found that KEGG pathways of the categories ‘Carbo-
hydrate Metabolism’ and ‘Excretory System’ were associ-
ated with the health traits, but not with the production
traits (with the exception of protein yield). Production
traits were strongly associated with – among others – the
categories ‘Amino Acid Metabolism’, ‘Digestive System’,
‘Lipid Metabolism’, and ‘Metabolism of Cofactors and
Vitamins’. Surprisingly, the category ‘Immune System’ was
found to be associated with the production traits but
with none of the health traits; together with ‘Arginine and
proline metabolism’, the two ‘Immune System’ pathways
are the only non-DGAT1 pathways associated with the
production traits.
The transcriptome of the mammary gland changes dur-
ing the lactation cycle, and these modifications reflect
its developmental and physiological activities at differ-
ent stages. The results of a recent study by Bionaz et al.
[39] on the cow mammary transcriptome during lac-
tation provide a rationale for understanding several of
the associations between KEGG pathways and the traits
observed here. All categories that were found associ-
ated in our study, except ‘Xenobiotics Biodegration and
Metabolism’, were also found in [39]. One of these shared
categories was the ‘Lipid Metabolism’ pathway ‘Glyc-
erolipid metabolism’. This was not entirely unexpected
considering that DGAT1 catalyses the final step of triacyl-
glycerol synthesis, and that there is a strong association
between fat content of milk and DGAT1 polymorphisms
[23]. Furthermore, differential gene expression during lac-
tation also impacted ‘Retinol metabolism’ in the cate-
gory ‘Metabolism of Cofactors and Vitamins’ [39], which
probably reflects the contribution of retinoic acid sig-
nalling to mammary gland morphogenesis and function
[40, 41]. Furthermore, it has been shown that retinol
metabolism involves retinol esterification, which is cat-
alyzed byDGAT1, and thus explains the striking influence
of the DGAT1 gene [42, 43] on fat yield.
Comparison of the gene expression patterns in the
mammary gland tissue of cows with and without mas-
titis has been used to identify genes and pathways
that have a role in host defense against infection [44].
Intersection of the pathways in the present data and
in the infection-based data revealed a marked overlap,
including the pathways ‘Chemokine signalling’, ‘Leuko-
cyte transendothelial migration’, ‘Retinol metabolism’,
and ‘Glycerolipid metabolism’. Interestingly, we observed
that these KEGG pathways were associated with produc-
tion traits rather than with health traits, which might
reflect the negative correlation between mastitis resis-
tance and milk production. However a multiple trait
variance decomposition analysis of mastistis and milk
production traits is required to disentangle the negative
genetic correlation. The overlap between KEGG pathways
presented here and those derived from transcriptomes
of infected or lactating mammary gland lend support to
the present genome partitioning approach as a means of
understanding the genetics of complex traits.
The discussion of these pathways is not meant to be
exhaustive but rather to give examples of the power of our
approach to reveal biologically meaningful pathways and
phenotypic traits.
Our LMM approach has several advantages. First, it
builds on a solid statistical modelling framework that
allows us to adjust for other known effects, such as gen-
der, age, and various lifestyle characteristics, and to use it
in populations with complex pedigree structures. Second,
it can be easily extended to handle multiple correlated
traits and thus be used to identify biological pathways that
underlie the genetic correlations. From a selective breed-
ing perspective, it would be very useful if this information
could be used to design selection strategies that limit the
influence of unfavourable correlations between complex
traits and diseases. Third, LMM are commonly applied
to predict the genetic value (or risk) in genomic selection
programs. Although our approach can be used to pre-
dict genetic values based on each marker set, further work
is required to assess if this would lead to more accurate
predictions of genetic values.
Our findings not only improve our understanding
of the biological basis of traits but also provide a
source of molecular information on candidate genes
and pathways that, when applied in breeding programs,
could lead to higher precision in the prediction of
genetic values and allow faster progress towards breeding
goals.
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Conclusions
In this study, we used a LMM approach to examine the
joint contribution of genetic markers associated with a
biological pathway to a complex trait. The random gene
sampling procedure allowed us to assess the statistical
significance of the estimated variance explained by the
biological pathways. This was done with a dataset that
has an inherently complex correlation structure due to the
population structure, and LD within the bovine genome
and the gene group itself. We identified several biological
pathways that were significant for both health traits and
milk production traits; thus, we show that the markers
associated to these pathways explain more of the genomic
variance and provide a better model fit than 95% of
randomly sampled gene groups.
We believe that the linear mixed model approach
provides a general framework to exploit and integrate
multiple layers of data from high throughput genome
technologies, potentially leading to improved understand-
ing of the genetic architecture of complex traits and
diseases.
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